All Companies
Ticker LMNL
This stock is no longer actively trading
You reached the page — here's exactly what LMNL is, and why it's out of scope for now.
What this ticker is
LMNL
Liminal BioSciences Inc.
NASDAQ
Healthcare
Biotechnology
Canada
Mkt cap $27.6M
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idi…
Why we can't analyze it yet
This ticker is delisted or inactive, so its financial data is frozen or incomplete and we don't produce a live analysis for it — the figures would be stale. Here's what the ticker is and why it's out of scope.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
delisted